Further evidence that paroxysmal nocturnal haemoglobinuria is a disorder of defective cell membrane lipid rafts

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 9, 2015, Pages 2193-2201

  Ratajczak, Mariusz Z ^a,b   Borkowska, Sylwia ^a   Mierzejewska, Kasia ^c   Kucia, Magda ^a,b   Mendek Czajkowska, Ewa ^b   Suszynska, Malwina ^a   Sharma, Vivek A ^a   Deptala, Andrzej ^b   Song, Wechao ^d   Platzbecker, Uwe ^e   Larratt, Loree ^f   Janowska Wieczorek, Anna ^f   Maciejewski, Jarek ^g   Ratajczak, Janina ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^f UNIVERSITY OF ALBERTA   (Canada)

^g TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Complement; CXCR4; Lipid rafts; PNH; S1P

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DECAY ACCELERATING FACTOR; FIBRONECTIN; FINGOLIMOD; MITOGEN ACTIVATED PROTEIN KINASE 3; STROMAL CELL DERIVED FACTOR 1; VERY LATE ACTIVATION ANTIGEN 4; AEROLYSIN; BACTERIAL TOXIN; GLYCOSYLPHOSPHATIDYLINOSITOL; LEUKOCYTE ANTIGEN; PORE FORMING CYTOTOXIC PROTEIN;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION ASSAY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL; IMMUNOSUPPRESSIVE TREATMENT; INTRACELLULAR SIGNALING; JURKAT CELL LINE; LIPID RAFT; MOUSE; NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; ANIMAL; BONE MARROW; C57BL MOUSE; CHEMOTAXIS; DRUG EFFECTS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; BACTERIAL TOXINS; BONE MARROW; CELL ADHESION; CHEMOKINE CXCL12; CHEMOTAXIS; FIBRONECTINS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; INTEGRIN ALPHA4BETA1; JURKAT CELLS; MEMBRANE MICRODOMAINS; MICE, INBRED C57BL; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 84940774754     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12605     Document Type: Article

References (26)

1. Lapidot T, Kollet O. The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization. Hematology Am Soc Hematol Educ Program. 2010; 2010: 1-6.
2. Bonig H, Papayannopoulou T. Hematopoietic stem cell mobilization: updated conceptual renditions. Leukemia. 2013; 27: 24-31.
3. Lévesque JP, Helwani FM, Winkler IG. The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization. Leukemia. 2010; 24: 1979-92.
4. Doan PL, Chute JP. The vascular niche: home for normal and malignant hematopoietic stem cells. Leukemia. 2012; 26: 54-62.
5. Ratajczak MZ, Lee H, Wysoczynski M, et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia. 2010; 24: 976-85.
6. Ratajczak MZ, Kim CH, Abdel-Latif A, et al. A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia. 2012; 26: 63-72.
7. Juarez JG, Harun N, Thien M, et al. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. Blood. 2012; 119: 707-16.
8. Golan K, Vagima Y, Ludin A, et al. S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. Blood. 2012; 119: 2478-88.
9. Brodsky RA. How do PIG-A mutant paroxysmal nocturnal hemoglobinuria stem cells achieve clonal dominance? Expert Rev Hematol. 2009; 2: 353-6.
10. Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood. 2009; 11: 6522-77.
11. Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995; 333: 1253-8.
12. Nishimura J, Kanakura Y, Ware RE, et al. Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine. 2004; 83: 193-207.
13. Szpurka H, Schade AE, Jankowska AM, et al. Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells. Br J Haematol. 2008; 142: 413-22.
14. Wysoczynski M, Reca R, Ratajczak J, et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood. 2005; 105: 40-8.
15. Ratajczak J, Kucia M, Mierzejewska K, et al. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient. Leukemia. 2012; 26: 1722-5.
16. Ratajczak MZ, Kim CH, Wojakowski W, et al. Innate immunity as orchestrator of stem cell mobilization. Leukemia. 2010; 24: 1667-75.
17. Borowitz MJ, Craig FE, Digiuseppe JA, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom. 2010; 78: 211-30.
18. Kim CH, Wu W, Wysoczynski M, et al. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia. 2012; 26: 106-16.
19. Molina H, Miwa T, Zhou L, et al. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor. Blood. 2002; 100: 4544-9.
20. Wu W, Kim CH, Liu R, et al. The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation. Leukemia. 2012; 26: 736-45.
21. Guan JL. Cell biology. Integrins, rafts, Rac, and Rho. Science. 2004; 303: 773-4.
22. Lamming CE, Augustin L, Blackstad M, et al. Spontaneous circulation of myeloid-lymphoid-initiating cells and SCID-repopulating cells in sickle cell crisis. J Clin Invest. 2003; 111: 811-9.
23. Mierzejewska K, Klyachkin YM, Ratajczak J, et al. Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow. Biomed Res Int. 2013; 2013: 814549.
24. Reis ES, Lange T, Köhl G, et al. Sleep and circadian rhythm regulate circulating complement factors and immunoregulatory properties of C5a. Brain Behav Immun. 2011; 25: 1416-26.
25. Risitano AM, Ricklin D, Huang Y, et al. Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria. Blood. 2014; 123: 2094-101.
26. Pawelec K, Matysiak M, Niewiadomska E, et al. Results of immunosuppressive therapy in children with severe aplastic anaemia. Report by the Polish Paediatric Leukaemia and Lymphoma Study Group. Med Wieku Rozwoj. 2006; 10: 832-9.